Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates

This publication has 39 references indexed in Scilit:

• Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer
  Molecular Therapy, 2011
• BALB/c Mice Show Impaired Hepatic Tolerogenic Response Following AAV Gene Transfer to the Liver
  Molecular Therapy, 2010
• Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood–Brain Barrier (BBB)
  Molecular Therapy, 2010
• RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
  Nature Biotechnology, 2010
• Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
  Nature Biotechnology, 2010
• The Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in Macaques
  Molecular Therapy, 2010
• Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors
  Proceedings of the National Academy of Sciences, 2009
• Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
  Molecular Therapy, 2009
• Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
  Nature Biotechnology, 2008
• Expanded Repertoire of AAV Vector Serotypes Mediate Unique Patterns of Transduction in Mouse Brain
  Molecular Therapy, 2008